Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Recruiting Phase 2 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01384513A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesTreatment